Knowledge for Growth is live again! On May 18 and 19, the biotech community will come together in Ghent and anicells will be there for sure. At the request of Flanders.bio, the at.las network is organizing a debate on CAR-T therapies. Nathalie Cools, CEO of anicells and co-founder of at.las, will expertly moderate this debate and will discuss, among other things, manufacturing challenges, regulatory and legal constraints and the position of CAR-T therapies in the patient journey. Join this lively debate. We’ll see you there!
Published on 16/05/2022